Atrás
Rango del Día
$113.66
$117.74
Rango de 52 Semanas
$102.97
$175.77
Volumen
403,004
Promedio 50D / 200D
$140.91
/
$138.89
Cierre Anterior
$116.35
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 134.0 | 0.3 |
| P/B | 3.1 | 2.9 |
| ROE % | 2.4 | 3.7 |
| Net Margin % | 6.6 | 3.8 |
| Rev Growth 5Y % | 2.4 | 10.0 |
| D/E | 0.3 | 0.2 |
Precio Objetivo de Analistas
Hold
$177.50
+52.6%
Low: $150.00
High: $200.00
P/E Futuro
58.5
EPS Futuro
$1.99
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
830 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$5.69
$5.54 – $5.79
|
1.5 B | 1 |
| FY2029 |
$4.49
$4.37 – $4.56
|
1.3 B | 1 |
| FY2028 |
$3.30
$2.64 – $3.79
|
1.1 B | 5 |
Puntos Clave
Revenue grew 2.43% annually over 5 years — modest growth
ROE of 2.40% is below average
Debt/Equity of 0.33 — conservative balance sheet
Generating 93.90M in free cash flow
P/E of 133.99 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13.93%
Crecimiento
Revenue Growth (5Y)
2.43%
Revenue (1Y)16.36%
Earnings (1Y)N/A
FCF Growth (3Y)11.94%
Calidad
Return on Equity
2.40%
ROIC1.60%
Net Margin6.62%
Op. Margin8.07%
Seguridad
Debt / Equity
0.33
Current Ratio8.37
Interest Coverage2.57
Valoración
P/E Ratio
133.99
P/B Ratio3.11
EV/EBITDA112.04
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.36% | Revenue Growth (3Y) | 8.05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 17.20% |
| Revenue Growth (5Y) | 2.43% | Earnings Growth (5Y) | -21.43% |
| Profitability | |||
| Revenue (TTM) | 738.26M | Net Income (TTM) | 48.89M |
| ROE | 2.40% | ROA | 1.66% |
| Gross Margin | 47.09% | Operating Margin | 8.07% |
| Net Margin | 6.62% | Free Cash Flow (TTM) | 93.90M |
| ROIC | 1.60% | FCF Growth (3Y) | 11.94% |
| Safety | |||
| Debt / Equity | 0.33 | Current Ratio | 8.37 |
| Interest Coverage | 2.57 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 133.99 | P/B Ratio | 3.11 |
| P/S Ratio | 8.87 | PEG Ratio | -0.65 |
| EV/EBITDA | 112.04 | Dividend Yield | 0.00% |
| Market Cap | 6.55B | Enterprise Value | 6.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 738.26M | 634.44M | 632.36M | 801.54M | 670.53M |
| Net Income | 48.89M | -25.51M | 35.60M | 185.96M | 128.29M |
| EPS (Diluted) | 0.86 | -0.46 | 0.63 | 3.24 | 2.24 |
| Gross Profit | 347.62M | 274.65M | 278.44M | 455.71M | 391.25M |
| Operating Income | 59.58M | -35.11M | 47.70M | 224.67M | 167.25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.95B | 2.83B | 2.83B | 2.53B | 2.36B |
| Total Liabilities | 843.57M | 856.95M | 866.34M | 620.90M | 608.29M |
| Shareholders' Equity | 2.11B | 1.97B | 1.96B | 1.91B | 1.75B |
| Total Debt | 689.95M | 686.25M | 711.80M | 422.96M | 366.05M |
| Cash & Equivalents | 566.02M | 757.36M | 751.32M | 523.46M | 603.81M |
| Current Assets | 1.14B | 1.07B | 1.11B | 998.12M | 931.68M |
| Current Liabilities | 135.83M | 126.79M | 164.94M | 404.20M | 375.26M |